Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus
Provided By GlobeNewswire
Last update: Feb 11, 2025
LP-310 Treatment Demonstrates Clinically Meaningful Reductions in Pain, Ulceration, and Inflammation Across All Key Metrics
Findings Highlight Favorable Safety Profile and Tolerability of Twice-Daily Oral Rinse
Read more at globenewswire.com
